Citizens & Northern Corp’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Citizens & Northern Corp’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,347	Closed	-$282K	–	137
2024 Q3	$282K	Buy	+6,347	New	+$272K	0.08%	109

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $18.1B AUM 15% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citizens & Northern Corp's XPH Position: Q4 2024 in Review

Citizens & Northern Corp sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2024, closing a stake of 6,347 shares — an estimated $282K sold.

Citizens & Northern Corp first reported a position in XPH in Q3 2024 and held it in 1 quarter. The position peaked at $282K in Q3 2024. 73 funds tracked by Wall St. Rank hold XPH as of Q4 2024.

Citizens & Northern Corp reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2024 after selling out during the quarter.
Citizens & Northern Corp sold 6,347 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2024, an estimated $282K.
Citizens & Northern Corp first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2024 and held it in 1 quarter.
Citizens & Northern Corp's State Street SPDR S&P Pharmaceuticals ETF position peaked at $282K in Q3 2024.
73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2024.

Based on Citizens & Northern Corp's 13F filing for Q4 2024, filed 31 Jan 2025.